GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Future 3-5Y EPS without NRI Growth Rate

TSMRF (Tsumura) Future 3-5Y EPS without NRI Growth Rate : 24.40 (As of Sep. 20, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tsumura Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Tsumura's Future 3-5Y EPS without NRI Growth Rate is 24.40.

Competitive Comparison of Tsumura's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Tsumura's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tsumura's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tsumura's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Tsumura's Future 3-5Y EPS without NRI Growth Rate falls into.


Tsumura  (OTCPK:TSMRF) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Tsumura Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Tsumura's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Tsumura Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
TSE:4887 TSE:4506 TSE:4547 TSE:4553 TSE:4521 TSE:4534 TSE:4551 TSE:4569 TSE:4559 TSE:4886 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
4540:Japan
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Website
http://www.tsumura.co.jp
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura Headlines

From GuruFocus

Full Year 2019 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024

Q2 2020 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research • 02-15-2024